High PD-L2 Predicts Early Recurrence of ER-Positive Breast Cancer

T-cell–mediated cytotoxicity is suppressed when programmed cell death-1 (PD-1) is bound by PD-1 ligand-1 (PD-L1) or PD-L2. Although PD-1 inhibitors have been approved for triple-negative breast cancer, the lower response rates of 25%-30% in estrogen receptor–positive (ER+) breast cancer will require...

Descripción completa

Detalles Bibliográficos
Autores principales: Chervoneva, Inna, Peck, Amy R., Sun, Yunguang, Yi, Misung, Udhane, Sameer S., Langenheim, John F., Girondo, Melanie A., Jorns, Julie M., Chaudhary, Lubna N., Kamaraju, Sailaja, Bergom, Carmen, Flister, Michael J., Hooke, Jeffrey A., Kovatich, Albert J., Shriver, Craig D., Hu, Hai, Palazzo, Juan P., Bibbo, Marluce, Hyslop, Terry, Nevalainen, Marja T., Pestell, Richard G., Fuchs, Serge Y., Mitchell, Edith P., Rui, Hallgeir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2023
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928763/
https://www.ncbi.nlm.nih.gov/pubmed/36652667
http://dx.doi.org/10.1200/PO.21.00498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928763/
https://www.ncbi.nlm.nih.gov/pubmed/36652667
http://dx.doi.org/10.1200/PO.21.00498

Ejemplares similares